Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SKEJBY DYREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   14.7% 11.4% 4.8% 12.0% 7.6% 24.2% 19.5% 19.3%   Credit score (0-100)   15 22 45 18 31 2 6 7   Credit rating   BB BB BBB BB BB B B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,343 2,597 3,166,895 4,636 5,111 368 0.0 0.0   EBITDA   363 258 661,462 581 -383 -5,823 0.0 0.0   EBIT   251 188 591,306 575 -582 -7,128 0.0 0.0   Pre-tax profit (PTP)   256.0 194.0 588,851.0 573.4 -590.0 -7,206.2 0.0 0.0   Net earnings   199.0 151.0 458,887.0 447.3 -608.1 -7,171.7 0.0 0.0   Pre-tax profit without non-rec. items   256 194 588,851 573 -590 -7,206 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   146 76.0 5,470 208 2,687 1,404 0.0 0.0   Shareholders equity total   324 285 584,046 581 2,679 -4,492 -4,617 -4,617   Interest-bearing liabilities   0.0 0.0 0.0 0.0 564 1,138 4,617 4,617   Balance sheet total (assets)   1,224 1,113 2,385,451 2,034 4,491 3,004 0.0 0.0   Net Debt   -550 -570 -1,199,276 -1,085 -183 601 4,617 4,617     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,343 2,597 3,166,895 4,636 5,111 368 0.0 0.0   Gross profit growth   95,649.9% 10.8% 121,844.4% -99.9% 10.2% -92.8% -100.0% 0.0%   Employees   5 5 5 11 14 14 0 0   Employee growth %   0.0% 0.0% 0.0% 120.0% 27.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,224 1,113 2,385,451 2,034 4,491 3,004 0 0   Balance sheet change%   112,090.7% -9.1% 214,226.2% -99.9% 120.8% -33.1% -100.0% 0.0%   Added value   363.0 258.0 661,462.0 580.9 -576.5 -5,823.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   34 -140 -64,762 -5,267 2,280 -2,588 -1,404 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.7% 7.2% 18.7% 12.4% -11.4% -1,938.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   42.0% 16.7% 49.8% 0.0% -17.8% -118.9% 0.0% 0.0%   ROI %   158.5% 64.0% 203.3% 0.2% -30.4% -150.4% 0.0% 0.0%   ROE %   122.7% 49.6% 157.1% 0.2% -37.3% -252.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   26.5% 25.6% 24.5% 28.6% 59.7% -59.9% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -151.5% -220.9% -181.3% -186.8% 47.7% -10.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 21.0% -25.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 2.9% 9.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.8 1.1 0.9 0.5 0.4 0.0 0.0   Current Ratio   1.0 1.1 1.2 1.1 0.7 0.5 0.0 0.0   Cash and cash equivalent   550.0 570.0 1,199,276.0 1,085.3 746.3 536.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   16.0 47.0 416,956.0 187.3 -471.3 -1,064.9 -2,308.7 -2,308.7   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   73 52 132,292 53 -41 -416 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   73 52 132,292 53 -27 -416 0 0   EBIT / employee   50 38 118,261 52 -42 -509 0 0   Net earnings / employee   40 30 91,777 41 -43 -512 0 0